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This work was started in an attempt to correlate 
total body metabolism with the metabolism at cell 
level. The work was carried out in the Biochemistry 
Department of the Western Infirmary, Glasgow, and the 
subjects were human patients. Because of this, the 
choice of cell was severely limited. Leucocytes were 
the most suitable since they have a high respiration 
rate and are nucleated. They can be obtained from 
the patient by simple venepuncture, and, with care, 
can be isolated as intact cells almost uncontaminated 
with erythrocytes. There is very little published 
work on the correlation between total body metabolism 
and cell respiration in the human subject. If a 
relationship could be shown to exist between the basal 
metabolic rate and the respiration of the leucocyte, 
it was intended to proceed with a study of the action 
of metabolic stimulants on the respiration rate of the 
leucocytes and correlate the results with the response 
of the body as a whole. Fortunately, it was found 
that a direct relationship did indeed exist between 
these two quantities and this thesis is a record of 




Circulating leucocytes are well suited for 
metabolic studies being the only easily accessible, 
free-floating, nucleated mammalian cells. They are 
readily obtainable in quantity, and can be counted 
with accuracy. Since they can be studied in the 
human patient they provide a tool for investigation 
of interest both to the clinician and to the biochemist. 
The only other cells that have been extensively used 
for research are spermatazoa and the cells of certain 
tumours such as the Ehrlich ascites tumour.
This work records an examination of the respiration 
of human leucocytes, under various conditions, including 
the effects of certain metabolic stimulants. In the 
examination of the data available in the literature, 
there are three main difficulties in attempting to 
compare the results with those obtained by other workers, 
and these difficulties are:-
(1) Different workers use leucocyte preparations which 
differ widely in origin. The literature records 
studies of both normal and leukaemic human leucocytes 
as well as leucocytes from other animal species,
(2) Although the analytical methods employed are 
reasonably/
3.
/reasonably standardised, the media in which the 
leucocytes are suspended during respiration studies 
vary from one laboratory to another and experience 
has shown that the results obtained depend to 
some considerable extent on the composition of 
the medium employed, and,
(3) The protocols have been expressed in a variety 
of different ways, e.g., in terms of dry weight, 
cell numbers, and cell nitrogen content.
Respiration in terms of cell numbers is thought 
to be the most suitable method of expressing the 
results and is the method employed here. Where 
the ,fQn notation is used (indicating activity per 
mg. dry weight of cells per hour) Beck and Valentine
(1953) and Bird, Clements and Becker (1951) have 
calculated that -
QO2 x 1>960 = microlitres O2 per 10̂ -® cells per
hour, and this equation is useful in comparing 
results expressed by two common methods.
The earliest study of the respiratory activity of 
leucocytes was carried out by Grafe (1911) who tried to 
explain the marked increase in the total oxygen consumption 
of the body in leukaemia by studying the gas exchange of 
the leucocytes of normal and leukaemic patients. He 
isolated the leucocytes by a rather crude method 
involving/
4.
/involving centrifugation of whole blood, removing 
and discarding the plasma, and re-suspending the red 
and white cells in a salt solution containing saponin. 
Using a Haldane-Barcroft apparatus, he obtained results 
equivalent to an oxygen uptake of 0.017 - 0 .0 3 7 m-mole 
per 10̂ -0 leucocytes per hour in a mixed group of bloods 
from myeloid and lymphatic leukaemia patients. Apart 
from these determinations, G-rafe made no comment on 
the usefulness of the method for research purposes.
In 1930> Warburg published his classical studies 
on cell metabolism, concluding that neoplastic 
transformation involved fundamental changes in the 
energy-supplying metabolic reactions. A large 
number of confirmatory papers strongly implied that 
here was one criterion for malignancy - high aerobic 
and anaerobic glycolysis and a moderately high 
respiratory rate. The later discovery of normal tissues 
possessing these characteristics (e.g., renal medulla 
and jejunal mucosa) resulted in an attempt to attribute 
the "cancer pattern" in normal tissue to injury to the 
cells. Thus began a large series of investigations 
to determine the fundamental difference between normal, 
injured and malignant tissue.
The field was reviewed by Kempner (1939) whose own 
studies on patients with myeloid and lymphatic leukaemia 
led/
5.
/lead him to the conclusion that the occurrence of 
high aerobic glycolysis in mature leucocytes was a sign 
of ageing and dying. ¥ictor and Potter (1 9 3 8,a) found 
consistent increases in both aerobic and anaerobic 
glycolysis in the lymph nodes of mice with spontaneous 
and transmitted lymphocytic leukaemia , when compared 
with the corresponding values obtained using normal 
mouse lymph nodes. These findings were confirmed 
by Hall and Furth (1942), but at the same time, they 
showed that there was little difference between the 
oxygen consumption of the lymph nodes of leukaemia 
mice and that of normal mouse lymph nodes.
Daland and Isaacs (1927) and Glover, Daland and 
Schmitz (1930) showed that the respiratory and 
glycolytic rates of leukaemic cells were slightly 
higher than thoseof normal human cells, but the 
difference was not very great. Soffer and Wintrobe 
(1 9 3 2) failed to confirm these findings, nor could 
they correlate the respiratory and glycolytic rates 
with the maturity of the cell population.
Ponder and Macleod (1938) evaluated the effects 
on metabolism of cell maturity by producing rabbit 
peritoneal exudates in rapid succession 60 that the- 
cells became younger and younger due to bone marrow 
stimulation. The oxygen consumption of the first 
exudate was 0.18 m-mole oxygen per 10l0 cells per hour, 
and/
6.
/and that of the fourth exudate, containing many 
immature forms, was higher hy 50$. An increase of 
400$ over the control value could he obtained hy 
creating repeated exudates in rapid succession.
Keihle and Spitzy (1951) reported studies on a 
group of normal and a group of leukaemie leucocytes.
They removed the hulk of the erythroeytes hy 
centrifugation and then isolated the leucocytes from 
the plasma, at the same time, showing that centrifugation 
was not harmful to the leucocytes. They then compared 
respiration, aerobic, and anaerobic glycolysis rates 
in groups of selected cases of varying differential 
white cell count. They claimed to he able to 
distinguish a difference in the aerohic glycolytic 
rates between a preparation containing 90$ of 
lymphocytes and one containing 80$ of lymphocytes, 
hut since they presented only the mean results of their 
different groups and made no calculation of the standard 
deviation, their claim to such a degree of accuracy 
must he considered doubtful. In this paper, they also 
produced evidence Showing that myeloid respiration rate, 
both normal and leukaemie, increased with increasing 
maturity of the cell population.
Perhaps the most important single factor in the 
study/
7.
/study of leucocyte respiration rates is the composition 
of the medium in which the cells are finally suspended. 
Some workers employ serum; others use simple crystalloid 
solutions of varying composition. In many cases where 
serum is used, it is not clear in the text whether 
normal or leukaemie serum has "been employed. And in 
most eases, no reason is given for any particular choice 
of medium.
Victor and Potter (1938,1) showed that mouse lymphoid 
and leukaemie cells have higher respiratory rates in 
normal serum than in Ringer1 s solution while the rates 
of anaerobic glycolysis are the same in hoth media.
Typical results showed Q02 values for leukaemie cells 
of 6.1 (in serum) and 4*9 (in Ringer’s solution).
This has been confirmed by others including Macleod and 
Rhoads (1939) who studied suspensions of rabbit peritoneal 
exudate leucocytes. They found Q02 averaging 4 .6  in 
Ringer's solution buffered to pH 7*0, and Q02 values 
averaging 7 *0 in serum neutralised with hydrochloric 
acid to pH 7*0.
It has been reported by eertain authors that 
leucocyte respiration is particularly susceptible to 
the effects of "crowding’', i.e., the respiration rate 
of leucocytes is not proportional to the cell count 
beyond/
8.
/beyond a certain limiting number of cells per unit 
volume, (Soffer and WintroBe (1932), Barron and Harrop 
(1929)). This was not confirmed By Bonder and Macleod 
(1936) who were quite emphatic that centrifugation, 
cooling, and "crowding0 did not interfere with 
leucocyte respiration.
More recently, Hartman (1952), using guinea pig 
exudate leucocytes in varying concentrations, found 
that a disproportion Between oxygen uptake and cell 
numBers per unit volume occurred only when the cells 
were suspended in serum, But that these two quantities 
were proportional to each other over a wide range when 
the leucocytes were washed and suspended in a 
physiological salt solution. Beck and Valentine (1952, 
a, B) examined homogenates of human leucocytes in isotonic 
potassium chloride and did not observe any "crowding” 
effects.
Hewer techniques of leucocyte isolation were Brought 
out By Bird, Clements and Becker (1951). They examined 
the oxygen consumption, glucose utilisation, and lactic 
acid production in normal human leucocytes and in 
leukaemie leucocytes. The leucocyte suspension was 
prepared By means of the "Bovine fibrinogen method".
This consists of adding a 5$ (w/v) solution of Bovine 
fibrinogen in saline to the Blood specimen; this Brings 
about increased rouleaux formation in the erythrocytes 
leading/
/leading to a rapid sedimentation. Sedimentation 
enables a large volume of plasma to be obtained, and 
this plasma contains the bulk of the leucocytes in the 
original blood. The fibrinogen does not appear to 
interfere in any way with the respiration or metabolism 
of the leucocytes. This ‘'bovine fibrinogen method*' 
was first introduced by Buckley, Powell and Gribson (1950) 
The leucocytes so obtained were suspended in a medium 
containing Ringer’s solution, plasma, and added glucose. 
Under these conditions, Bird, Clements and Becker found a 
mean oxygen consumption of 0 .2 3 m-mole oxygen per 10 -̂ ° 
cells per hour with normal leucocytes, and a mean oxygen 
consumption of 0 .1 0  m-mole oxygen per ICP-̂  cells per hour 
for the leucocytes obtained from cases of chronic myeloid 
and lymphocytic leukaemias. However, the standard 
deviation of each group was so large that the authors 
were not prepared to regard the difference as significant 
They also observed a low glucose utilisation and lactic 
acid formation in the leucocytes from cases of lymphatic 
leukaemia and these they regarded as significantly 
different from the normal controls.
A later modification replaced the bovine fibrinogen 
by dextran which also increases the erythrocyte 
sedimentation rate. McKinney, Bundles and Martin (1952) 
introduced this method, and using it, they found a 
leucocyte/
1 0 .
/leucocyte mean oxygen uptake of 0.28 m-mole oxygen per 
1010 cells per hour when the leucocytes were suspended 
in a medium containing plasma and Hank1ssolution.
Beck and Valentine (1952, a) studied the respiration 
and aerohic glycolysis of leucocytes isolated hy the 
fibrinogen method (see ahove) from normal and leukaemie 
hloods. Three groups of patients were employed, (l) 
normals, (2) cases of chronic myeloid leukaemia (average 
leucocyte count 100,000 cells per cu.mm. with 9Gf> myeloid 
cells) and (3 ) cases of chronic lymphatic leukaemia 
(average leucocyte count 124,000 cells per cu.mm. with 
93i° lymphocytes).. The homogenised leucocytes were 
finally suspended in a medium of isotonic potassium 
chloride to which had heen added a buffered (pH = 7.4) 
fortified system containing adenosine triphosphate, 
diphosphopyridine nucleotide>cytochrome C, magnesium 
and phosphate ions, with glucose as the main substrate. 
With normal leucocytes, they found an oxygen consumption 
of 0.40 +^0.17 m-mole per 10*^ cells per hour, which 
is rather higher than the values found by most other 
workers. The figures for cases of chronic myeloid 
and chronic lymphatic leukaemia cases were 0.12 + 0 .0 3  
and 0.11 * 0.10 respectively. With both types of 
leukaemia they also found a markedly reduced glucose 
utilisation rate and a markedly r.educed lactic acid 
production rate.
The many reported biochemical differences (especially 
differences in oxygen consumption rates) between normal 
and leukaemie leucocytes suggest the possibility of 
different metabolic pathways in the two types of cell.
The intermediate carbohydrate metabolism has been studied 
by a number of workers, especially by Wagner and 
Reinstein (1950). They investigated the breakdown of 
glycogen in leucocytes and found that the reaction was 
catalysed by a phosphorylase, identical as far as they 
could discover, with the phosphorylase occurring in 
other tissues. In leucocytes isolated by the fibrinogen 
method from citrated horse blood they demonstrated the 
formation of glucose-l-phosphate, glueose-6-phosphate, 
fruetose-6-phosphate, fructose-1 :6-diphosphate, and 
phosphoglycerie acid, and inferred that the catabolism 
of glycogen followed the same pathways as in other 
tissues.
McKinney, Mar tin, Bundles and G-reen (1953) studied 
the respiratory and glycolytic activities of human 
leucocytes and concluded that the carbohydrate 
breakdown involved the usual Krebs’ cycle. They also 
gave evidence that intracellular oxidation may pass 
through the cytochrome system.
All the available evidence favours the conclusion 
that leucocytes have a pathway for oxidation similar 
to that found in other tissues, and that these cells 
have/
12
/have a high rate of aerohic glycolysis. McKinney 
et al. (1953) go further and state that the difference 
between intact and homogenised leucocytes to the effects 
of intermediate products of metabolism and to various 
inhibitors, may be correlated with cell permeability, 
and that the response of leucocytes to certain chemical 
agents parallels the pharmacological effects of these 
agents in the intact animal.
After 1953» there are very few reports of work 
on the respiration of leucocytes. Cooper and 
Fitzgerald (1958) examined rat lymphocytes suspended in 
a Krebs-Ringer-phosphate medium and found an oxygen 
consumption of 0.24 + 0 .0 3 ju. mole oxygen per 1 0 1 cells 
per hour. Addition of glucose to a final concentration 
of 100 mg. per 100 ml. did not alter the respiration 
rate in the first two hours. The oxygen consumption 
was proportional to the cell concentration over the 
range I6-I3O x 10^ lymphocytes per ml. They also 
stated that 5 hours after incubation in Warburg flasks 
at 37°C., the lymphocytes still showed their characteristic 
pseudopodial movements.
The latest review of the subject was by Valentine 
(1 9 5 6) who covered the work on leucocytes in the period 
1 9 5 3 -5 6 and concluded by saying that studies on the 
biochemical activity of leucocytes are in an early 
formative period, and represent attempts to get inside 
and/
/and explore its metabolic machinery. It is apparent, 
he states, that morphologically identical cell 
populations such as those of chronic myeloid leukaemia 
and polyeythaemia rubra vera in the leukaemoid phase, 
may continue to show widely different metabolic 
capacities. It is known that biochemical changes 
precede clinically detectable leukaemia as proved by 
studies on the atom bomb survivors of Hiroshima and 
Nagasaki (Moloney and large, 1954)* This work is 
a further exploration of the metabolism of leucocytes 
under various selected conditions.
Metabolic Action of Salicylate.
In 1916, Denis and Means first observed that 
administration of salicylate increased the oxygen 
consumption and the carbon dioxide production in 
man. This finding has been repeatedly confirmed 
in man, e.g. by Cochrane (1952, 1954), and in 
experimental animals, e.g. by Meade (1954), Tenney 
and Miller (1955) and Reid (1957). Although 
salicylate increases the minute pulmonary ventilation, 
it has been demonstrated that the increase in basal 
metabolic rate following salicylate administration 
is not dependent on the increase in respiratory 
work./
14.
/work. Decapitated or curarized dogs, maintained 
in a total body respirator designed to keep constant 
ventilation, showed the same oxygen consumption in 
response to salicylate administration as the intact 
animal (Tenney and Miller, 1955). It has also been 
shown by Erody (1 9 5 6), that the oxygen consumption 
of tissues removed from salicylate-treated animals 
is greater than the oxygen consumption of the 
corresponding tissues of control animals, Sproull
(1 9 5 4) and Smith and Jeffrey (1956) have shown that 
salicylate, added in vitro, increases the oxygen 
consumption of isolated tissue and of mitochondrial 
preparations. These increases in oxygen consumption 
are accompanied by reduction in the esterification of 
organie phosphate, i.e., salicylate uncouples oxidative 
phosphorylation (Erody, 1956)1 This is now believed 
to be one of the main pharmacological actions of 
salicylate*
The effect of salicylate is strikingly similar 
to that of 2 :4—dinitrophenol which increases the 
basal metabolic rate in the intact animal (Cutting, 
Rytand and Tainter, 1934) (Simkins, 1937) and also 
increases the oxygen consumption in tissue slices 
(Goldberg, Wolff and Creep, 1955). lardy and 
Wellman (1952) and Packer (1957) have shown that 
2 :4-dinitrophenoi uncouples oxidative phosphorylation 
in/
15.
/in isolated mitochondrial preparations*
Sproull (1954) has shown that sodium salicylate 
has two separate effects on the respiratory rate of 
mouse liver slices, (l) an initial stimulation 
followed “by (2 ) a depression of respiration at 
higher salicylate concentrations. It cannot he 
assumed that these effects are universal, occurring 
in all tissues, hut it is reasonable to suppose that 
they are not confined to the liver. In the past, 
such effects have heen particularly associated with 
the action of 2:4-dinitrophenol* But stimulation 
of respiration is not the only common factor in the 
effects of salicylate and 2 :4-dinitrophenol on 
tissue metaholism. Both substances are glycogenolytic 
(Magne, Mayer and Plantefol, 1933 > Lutwak-Mann?* 1942, 
Sproull, 1954); both are diaphoretic and increase 
nitrogen excretion in the urine. Body weight falls 
after repeated administration, and polyuria follows 
withdrawal (Majine et al., 1933> a, h); Reid, Watson 
and Sproull, 1950).
The action of salicylate in reducing hyperglyeaemia, 
glycosuria and ketonaemia in some diabetic patients 
has long been known. In the rat, both sodium 
salicylate and acetyl-salicylic acid are capable of 
reducing the hyperglyeaemia and the glycosuria of 
diabetes/
1 6 .
/diabetes induced "by partial pancreatectomy (Ingle,
1950), or induced by alloxan (Smith., Meade and Bronstein, 
1952), or induced by cortisone (Smith, 1952). The 
mechanism of this action of salicylate is not known. 
Salicylate is unlikely to act in diabetes by 
reducing gluconeogenesis, for in normal rats, salicylate 
administration produces a negative nitrogen balance 
(Winters and Morrill, 1955; Penmall, 1956).
Manchester, Randle and Howard-Smith (1958) 
re-investigated this effect by studying the action 
of salicylate on the uptake of glucose by the rat 
diaphragm in a medium buffered by bicarbonate. Their 
observations showed that sodium salicylate increased 
glucose uptake and potassium loss from the tissue, 
and it also decreased the incorporation of^C-lahelled 
glycine, lysine and glutamic acid into the protein of 
the tissue. This finding supports the suggestion of 
Reid, Macdougall and Andrews (1957) that salicylate 
stimulates metabolism in peripheral tissues* These 
authors also observed that salicylate increases the 
basal metabolic rate of both diabetic and non—diabetic 
subjects.
In 1955,'Brody carried out extensive investigations 
on the in vitro action of salicylate 011 mitochondrial 
preparations, and compared the results obtained with 
the effects of 2 :4-dinitrophenol on similar preparations.
He/
1^«
/He found that a concentration of 2 x 10“%  salicylate 
depressed the oxygen consumption hy about 20$ and 
completely inhibited the uptake of inorganic phosphate 
(P:0 = 0). Qualitatively similar results were 
obtained with 2:4-dinitrophenol. Several nitrated 
andhalogenated phenols, when added to mitochondrial 
preparations, accelerate the liberation of inorganic 
phosphate from adenosine-triphosphate (Hunter, 1951; 
Potter and Recknagel, 1951). It has been suggested 
that the effect of 2 :4-dinitrophenol in uncoupling 
oxidative phosphorylation, and its effect in 
catalysing the liberation of inorganic phosphate 
from adenosine-triphosphate are related in some 
way, although the nature of the relationship is still 
obscure. Sodium salicylate, like 2 :4-dinitrophenol, 
catalyses the hydrolysis of adenosine-triphosphate, 
but a higher concentration of salicylate is required 
than that needed to uncouple oxidative phosphorylation.
18.
Thyroid Hormone.
The fundamental effect of thyroid hormone is 
to increase the speed of normal metabolic processes 
in all cells of the body except the thyroid, spleen, 
lymph nodes, thymus, gonads and brain (Barker, 1955). 
This effect can be dsaonstrated by the increase in 
oxygen consumption both in the intact animal and in 
surviving isolated tissue. Y/hether the increased 
oxygen consumption is itself the fundamental reaction, 
or whether it is increased speed of some specific 
enzyme process, has still to be decided. In the 
complete absence of thyroid hormone, cellular 
activity still proceeds, but the rate of oxygen 
uptake is about 40-45^ lower than normal.
The principal secretion of the thyroid gland is 
thyroxine, but small and variable amounts of triiodo­
thyronine are also excreted. These two amino acids 
are removed from the circulation mainly by the liver, 
but also to a small extent by the kidneys. There 
are reasons for believing that neither of these two 
compounds is the true thyroid hormone, and the question 
of the moment in thyroid biochemistry is the precise 
nature of the chemical compound which stimulates 
peripheral tissue and whose precursor had its origin 
in the thyroid gland.
It/
/It has long been known that there is a latent 
period after the administration of various thyroid 
preparations and substances isolated from the thyroid 
gland, before any metabolic stimulation can be 
observed. With dedicated thyroid gland, this latent 
period is of the order 1 0 -1 4 days; with thyroxine, 
the latent period lasts for several hours. In the 
case of thyroxine, it was originally assumed that 
this latent period corresponded to the time 
required for the thyroxine.to react with protein 
to give thyroglobulin, but in his general review 
of the subject, Harington (19§5) pointed out that 
such a theory would only introduce an entirely 
unnecessary complication.
The discovery of triiodothyronine was one of 
the most important discoveries in the field of 
thyroid biochemistry during the last few years, 
and brought the hope of finding a solution to the 
problem of the latent period. After its 
identification in plasma and a study of its 
physiological properties by G-ross and Pitt-Rivers
(1 9 5 2), it was thought that this compound might be 
the active form of the thyroid hormone which 
investigators had been seeking. By the same 
standards as are applied to thyroxine, triiodothyronine
20.
/is a thyroid hormone. Both substances are formed 
in the thyroid gland and both are secreted into the 
blood stream; they have the same physiological 
actions but quantitatively, triiodothyronine is the 
more active. Gross, Pitt-Rivers and Thifeault (1953) 
showed that triiodothyronine has exactly the same 
latent period as thyroxine. (The problem of the 
latent period remained unsolved and Klemperer (1955) 
concluded that "the latent period might correspond 
to the formation of some active form of hormone, 
different from both thyroxine and triiodothyronine”.
Harington and Pitt-Rivers (1952) and Pitt-Rivers 
(1953) succeeded in synthesising several acetic acid 
derivatives of the thyroid hormones. Pitt-Rivers
(1953) showed that triiodothyroacetic acid (commonly 
contracted to TRIAC) has the same physiological 
actions as triiodothyronine. Thibault and Pitt-Rivers 
(1955, a, h) tested the effects of these acetic 
derivatives of thyroxine on the respiration of tissue 
slices and found that, in contrast to thyroxine and 
triiodothyronine, they produce an immediate effect 
on the respiration rate. They therefore concluded 
that the thyroid hormones (thyroxine and triiodothyronine) 
became metabolieally active only after their conversion 
to/
21 .
/to the corresponding acetic derivatives*
It was later discovered that the muscle of 
thyroidectomised rats, after injection of physiological 
dosea of 3:5:3‘-triiodothyronine contained 3 :5 O 1- 
triiodothyroaeetic acid and 1-diiodothyronine.
I  I ___  COOH~°~<C==̂ >CH2-CH
I  n h2




/  3 - 5 - 3'  triiodothyropyruvic acid
COOH
3 - 3 '  diiodothyronine
v
CHo COOH
3 - 5 - 3 '  trilodothypoqcetic acid
22 .
The above formulae and interactions show the 
probable pathways ror the metabolism of triiodo­
thyronine, (1 ) partial deiodination without change 
in the alanine residue, and (2 ) oxidative deamination 
and decarboxylation of the amino acid side chain* 
Presumably the same interactions may take place with 
thyroxine giving rise to the corresponding acetic 
derivative 3 :5:3 1*51-tetraiodothyroacetic acid which 
has also been isolated in small quantity from plasma.
Triiodothyroaeetic acid has been detected in 
the receptor cells of muscle and kidney. Either or 
both of these iodothyroacetic acids may be the. active 
form of the thyroid hormone. The point has not yet 
been decided.
The actions of these acetic derivatives have been 
extended in other directions. Pitt-Rivers (1953) 
showed that they could reverse the thiouraeil-induced 
goitre of rats; Bruce, Pitt—Rivers and Sloviter (1956) 
found that they restored the altered plumage of 
thyroidectomised birds to normal; Berman and Pitt- 
Rivers (1 9 5 5) administered these acids to human cases 
of myxoedema and observed a subsequent loss of weight 
and fall in the blood cholesterol concentration;
Heimberg, Park, Isaacs and Pitt-Rivers (1955) showed 
that they produced an immediate stimulation of oxygen 
consumption and glycolysis in ascites-tumour cells.
The available evidence strongly supports the 
view that the latent period represents the time 
necessary for the conversion of the thyroid hormones 
to the metabolieally active acetic derivatives. The 
enzymes necessary for this interconversion are 
normally present in all tissues. La Chaze and 
Thibault (1952) first identified the amino acid 
oxidase which can catalyse the conversion of all 
aromatic amino acids to the corresponding acetic 
acid derivatives. Certain tissues, e.g., thyroid, 
spleen, lymph nodes, etc., which are very rich a 
decarboxylase are probably poor in the amino acid 
oxidase necessary for this reaction, and these 




The oxygen consumption of leucocytes was 
determined hy the direct method using air as 
the gas phase at 37°C* in a Rotary Wfarburg apparatus 
made "by Braun of Melsungen, Western Germany* The 
flasks and manometers were calibrated by the method 
described by Dixon (1943). The flasks were shaken 
at 80 oscillations per minute.
Isolation of Leucocytes:
Blood specimens were collected during the early 
forenoon from fasting and resting (basal) subjects* 
4 0 -5 0 ml. blood wa6 withdrawn from the median 
basilic vein using a wide-bore needle and was 
transferred directly to a large siliconed tube 
containing heparin (100 units). Sedimentation of 
the erythrocytes was accelerated by the addition of 
1 volume of Dextraven (Benger’s dextran solution,
Sfo (w/v) solution of dextran in 0.9^ sodium 
chloride solution) to 5 volumes of blood. The two 
were gently mixed and allowed to stand for 30 
minutes at 4°0. The supernatant plasma (containing 
the leucocytes) was then transferred by a siliconed 
pipette into siliconed centrifuge tubes. The plasma 
was centrifuged at 50 g. for 10 minutes and the 
supernatant/
25.
/supernatant decanted and discarded. The sediment 
was re-suspended in a modified Krebs' buffer (see below) 
and so adjusted that the final suspension contained 
5 0 -7 0 x XO6 leucocytes per 3 .0  ml.
The technique does not effect complete separation 
of leucocytes and erythrocytes. The ratio of 
leucocytes to erythrocytes in the final suspension 
was of the order 1 : 2 but since the oxygen 
consumption of leucocytes is at least 100 times 
greater than the oxygen consumption of erythrocytes, 
the presence of these contaminating erythrocytes may 
be ignored. Other types of cell present in the 
suspension were reticulocytes and platelets. 
Seticulocytes are juvenile red cells; they contain 
reap ants of the basophilic ribonucleoprotein which 
was present in larger amounts in the cytoplasm 
of the nucleated precursors from which they were 
derived. The reticulocyte count is 0.2 - 2 .00^ 
ox the total red cell count. Since in the final 
suspension of leucocytes, the red cell:white cell 
ratio is 2 :1 , the reticulocyte :white cell ratio 
will he of the order of 0 .0 0 1 — 0 .0 1 0 :1 and is so 
small that it may be disregarded.
The platelets in the blood are active with 
respect to reparation and carbohydrate metabolism 
(Campbell, Small, loPilato and Dameshek (1957)).
Their/
/Their oxygen uptake is of the order of 0,003 Jim. per 
hour per 10? platelets (Campbell, Small and Dameshek 
(1956)), Since the platelet count is 150,000 -
400,000 as against 5,000 - 10,000 per cu.mm. for 
leucocytes, the question arises whether contamination 
with leucocytes will introduce a large error in 
determination of respiration of leucocytes. However, 
during the separation of the leucocytes, after the 
sedimentation of the erythrocytes, the supernatant 
plasma containing leucocytes plus platelets is 
centrifuged at 50 g. At this speed, the leucocytes 
are precipitated while the platelets are almost 
totally still suspended in the plasma* Thus in 
the suspension of leucocytes used in these studies, 
the few reticulocytes present do not significantly 
contribute to the total respiration of the cells 
in the Warburg flasks.
Each Warburg flask contained approximately 
50 x lO^ leucocytes (i.e., 3.0 ml. of the suspension) 
and all estimations of oxygen consumption were 
carried out in duplicate*
Buffer Medium;
The buffer solution used was a modification of 
the Krebs Medium II Buffer (Krebs, 1950). This is a 
calcium-free medium containing sodium, potassium, 
magnesium/
/magnesium, chloride and sulphate in approximately 
the same concentrations as occur in plasma and is 
recommended as the best medium, to use for human 
ceils or tissue. Phosphate is about 20 times 
higher and bicarbonate about 10 times lower than 
the corresponding concentrations in plasma.
Krebs medium II Buffer also contains pyruvate, 
xumarate and glutamate v/hich. were omitted from 
the modified buffer used in this work. In addition, 
the glucose concentration was increased to a final 
value of 100 mg. per 100 ml.
The modified buffer solution used had the 
following composition:—
83 volumes 0 .90$ (w/v) sodium chloride,
4 volumes 1 .15$ (w/v) potassium chloride,
1 volume 2 .11$ (w/v) anhydrous potassium
dihydrogen phosphate,
1 volume 3.82$ (w/v) magnesium sulphate
heptahydrate,
3 volumes 1 .30$ (w/v) sodium bicarbonate,
18 volumes sodium phosphate buffer mixture.
The sodium phosphate buffer solution consisted of 
100 volumes 0 .1  M d is odium hydrogen phosphate,
25 volumes 0.1 M sodium dihydrogen phosphate.
In order to minimise bacterial growth in the 
medium the glucose was not added to the medium 
until/
/until the day of use. Normally about 20 ml. of 
medium were required; to this was added 20 mg. of 
glucose thus bringing the concentration of glucose 
to 100 mg. per 100 ml. Compared with plasma, the 
greater part of the bicarbonate buffer is replaced by 
a phosphate buffer of the same pH and of approximately 
equivalent concentration. The solution has a 
relatively high concentration of phosphate - hence 
the omission of calcium.
The pH of the medium was finally adjusted to 
7 .4 0  + 0.05 by the addition of iso-osmotic disodium 
hydrogen phosphate solution containing 1.725 g. of 
the anhydrous salt per 100 ml.
It is essential that the pH be maintained within 
the limits 7.35 to 7.45 > otherwise the respiration 
of the leucocytes is grossly disturbed. The most 
critical factor is pH control. The buffer system 
suggested by McKinney, Rundles and Martin (1952) 
was not found to be satisfactory and the difficulty 
was traced to the pH which was always less than 7.30* 
In any experiment where the cells failed to respire 
properly, it was found that the pH was outwith the 
required limits of 7.35 to 7*45* This occasionally 
happened early in the work and was found to be due
29.
/to inadequate removal of acid after the flasks, etc.,
had "been siliconed.
Oxygen consumption of the subject was measured 
by the Benedict-Roth apparatus. White cell counts 
were carried out in a haemocytometer using the 
technique described by Whitby and Britton (1953), 
and taking the mean of two independent counts.
Blood films for differential cell counts were 
stained by leishmann's method and examined in the 
usual way. Plasma salicylate was determined by 
the method of Trinder (1954)•
It was important to ensure that the relationship 
between oxygen consumption and cell numbers per flask 
was linear over the range likely to be encountered 
with the large numbers of cells obtainable from 
leukaemia patients. The primary object of such 
an experiment was to prove that the capacity of the 
buffer solution used, was sufficient to cope with 
the metabolic products of large numbers of cells, 
and at the same time, to show that with normal 
blood, there was a considerable reserve of buffering 
power. Leucocytes were isolated from three different 
patients suffering from leukaemia and it was shown that 
the oxygen consumption per hour per 10*7 cells was 
constant in each case when the number of leucocytes 
per/
30.
/per flask was varied from 3.0 x 10? cells to 20.0 x
10*7 cells per flask. The results are given in Table I.
TABLE I. Effect of increasing the Number of Cells per
Elaak on the Oxygen Uptake per Hour per 10^ Cells.
Oxygen uptake in jx moles per hour per 10^ cells
No. of cells 
per flask.
Patient A. Patient B. Patient C.
3.0 x 10? 0.125 0 .1 0 3 0.152
6.0 x 10? 0.129 0.101 0.157
9.0 x 107 0.125 0.108 0.150
12.0 x 107 0.127 0.105 0.157
20.0 x 107 0.123 0.107 0.152
The reproducibility of the method of determining 
oxygen consumption is shown by a comparison between 
duplicate analyses of the same eell preparation. 
Results are given in Table II.
31.
TABLE II* Differences between Duplicate Estimation of 
the Bate of Oxygen Consumption.
All results are given in p moles C>2 per hour per 10? 
leucocytes.
Duplicates. Duplicates.






















































0 .0 0 4
0 .0 1 4
0 .0 0 4
0 .0 0 5
0 .0 7 3
0 .0 9 5























































0 .0 0 3
0 .0 0 4
0 .0 0 4
TABLE II. Mean of 39 differences......... 0.007
S.I).........   0.011
The experiments tabulated in Table II cover the 
range of the great majority of estimations carried 
out in this work. Reproducibility over this range 
is satisfactory, and the accuracy of the method 
appears sufficiently good for the purposes for 
which it has been used.
Studies of the oxygen consumption of leucocytes 
were carried out on:-
(1) Normal healthy subjects (medical students),
(2) Patients with rheumatic fever who were being 
treated with sodium salicylate, and whose 
differential leucocyte count was within 
normal limits,
(3) Cases of hypothyroidism and of hyperthyroidism.
In vitro experiments were carried out with the 
metabolic stimulants, sodium salicylate at 
concentrations of 10 to 160 mg. per 100 ml. medium, 
and triiodothyroacetic acid (TRIAC) at concentration 
of 10 to 50 jug. per 100 ml. medium. These in vitro 
studies were carried out on:-
(1) Normal healthy subjects (medical students),
(2) Cases of chronic myeloid leukaemia and of chronic 
lymphatic leukaemia.
THE OXYGEN CONSUMPTION OP NORMAL LEUCOCYTES.
The rate of oxygen consumption of normal 
leucocytes from normal individuals was determined 
in a series of 16 cases. These controls were 
healthy young adults of both sexes. They came 
to hospital in a fasting state and were made to 
rest for at least 30 minutes. The basal metabolic 
rate was first determined and blood was taken by 
venepuncture immediately afterwards. In certain 
cases, the procedure was repeated on the same 
individual a few days later in order to assess the 
day-to-day variation. Results are shown in Table III.
TABLE III. The Oxygen Consumption of Normal Leucocytes.
All results are given in p. moles O2 per hour per 10? 
cells.
Each figure quoted is the mean of two duplicate analyses. 
In 6 cases, the oxygen consumption was measured on two 
separate occasions at intervals of a few days*
34.
TABUS III. The Oxygen Consumption of Formal Leucocytes.
Cell oxygen consumption.
Subject. First estimation. Second estimation.
1. 0.079 0.081
2 . 0 .0 8 6 0 .0 9 0
3 . 0.086 0 .1 0 3
4 . 0 .0 8 8 0 .0 9 9
5 . 0 .0 9 1 0 .0 8 8
6. 0.096




1 1 . 0.123
1 2 . 0.123
1 3 . 0.125
1 4 . 0 .1 3 8 -
15. 0.145
16. 0.155
Mean of 16 values 0.111 
S.D. 0.023
Results are expressed as pa. per hour per 10 cells.
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THE EFFECT Off EXERCISE ON THE OXYGEN CONSUMPTION OF 
LEUCOCYTES.
During investigation of the respiration of 
human leucocytes it was observed that moderate 
exercise "by the donor, prior to venepuncture, was 
associated with an increase in the rate of oxygen 
consumption. A short series of experiments was 
then carried out to determine the effect of such 
exercise on "both the oxygen consumption of 
leucocytes and the metabolic rate of normal subjects. 
The subjects used were normal healthy young adults 
aged 18 to 29 years. They were in the fasting 
state, and rested for at least 30 minutes before 
the experiments began. The basal metabolic rate 
was then determined over a period of 5 minutes and 
blood was then collected by the method described 
above. The basal metabolic rate was determined a 
second time. The subjects then walked up and 
down two flights of stairs four times at the normal 
rate taking approximately 3-4- minutes. A third 
recording of the metabolic rate was made, and a 
second specimen of blood was taken. Finally, the 
metabolic rate was determined for a fourth time.
The average of the first and second recordings was 
taken/
36 .
/taken as the basal metabolic rate, and the average 
of the third and fourth recordings was taken as the 
metabolic rate after exercise.
It is known that exercise may alter the number 
of circulating leucocytes; but the fact that results 
are expressed in jji moles oxygen per hour per 10? 
cells, eliminated any variation in the total white 
cell count. The data given in Table IT shows that 
the differential leucocyte count is not significantly 
altered.
37.
TABLE IV. The Total Leucocyte Count and the
Differential Leucocyte Count Before 
and after moderate Exercise.
Total Leucocyte Count is expressed as cells per cu. mm. 
Blood.
B ss Before exercise.









1. B. 5,250 63 31 4 2 0A. 6 ,9 0 0 60 351 3i 1 0
2. No total or differential leucocyte counts were made.
3. L. 6,600 58 33 6 3 0A. 6,900 59 33 5 3 0
4. B. 5,160 72 22 5 1 0
A. 4,900 69 24 5 1 1
5. B. 6,700 72 22 4 J-s 1S'A. 10,600 70 24 5 1 0
6. B. 5,480 66 28 1 0
A. 5,700 68 27 4 1 0
38.
The effect of this standard exercise test on the 
oxygen consumption of leucocytes is shown in Table V 
(a and b) where the effect is compared with the 
corresponding alteration in the metabolic rate.
TABLE 7 (a). Effect of Exercise on the Respiration of 
Leucocytes.
Leucocyte oxygen consumption jji moles O2 per hour per
10? cells.
Subject. Before exercise . After exercise.
Percentage
Increase,
1. 0.086 0.148 62 $
2. 0.138 0.202 46$
3. 0.112 0.190 57$
4. 0.155 0.265 71$
5. 0.091 0.136 49 $
6. 0.096 0 .1 3 0
Ayerage increase.
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TABLE V (b). The corresponding Effect of Exercise on 
the Subjects Oxygen Consumption.
Subject's Oxygen Consumption ml. oxygen per minute.
Surface
‘̂r§a* PercentageSubject. m * Before exercise* After exercise. Increase.
1. 1.82 226 246 %
2. 2.01 359 437 22 #
3. 1.86 199 298 49 #
4. 1.88 203 279 yii°
5. 1.92 272 390 43#
6. 1.78 218 235 8 #
Average increase.... 28#
The effect of exercise on the respiration of 
leucocytes is twice as great as its effect on total 
body oxygen consumption. further, more consistent 
results are obtained by measuring the oxygen 
consumption of the isolated cells.
The possibility that the change in leucocyte 
oxygen consumption was due in some way to venepuncture 
was considered. Blood samples were taken from three 
normal subjects, exactly under the conditions described 
above, except that the exercise was omitted. The chan 
in/
/in oxygen consumption "between the two samples was 
-11#, +5#> and -3#. Such figures cannot account 
for the changes observed in Table V (a).
Two conclusions were drawn from these results
(1) that a Msubstance" may appear in the blood as 
a result of moderate exercise, which has the 
property of stimulating the metabolic activity 
of the leucocytes in vitro, and,
(2) that in previous work on the respiration of 
leucocytes, the discordant results reported 
(e.g., see Beck and Valentine, 1953) ^ay have 
been due to the fact that preceding muscular 
activity was not taken into account.
These two conclusions will be dealt with in the 
discussion (see p. 87 ).
METABOLIC STIMULATION BY SALICYLATE.
It is known that salicylate stimulates body 
metabolism. The plasma salicylate concentration 
has been directly correlated with the metabolic 
rate by Reid (1957) in the rabbit, and by 
Alexander and Johnston (1958) in man. With this 
in mind, experiments were designed to discover if 
there were any correlation between the plasma 
salicylate concentration and the oxygen consumption 
of leucocytes in vitro in man.
Two patients who were still on salicylate 
therapy, were selected as suitable subjects.
Their total and differential leucocyte counts were 
within normal limits. In both cases, 10 different 
specimens of blood were collected at intervals as 
the dosage of acetyl-salicylic acid was increased, 
and the plasma salicylate concentration and the rate 
of oxygen consumption of the leucocytes were 
determined on each specimen.
The leucocytes were suspended in the usual 
buffer solution (p.27 ) which contained no salicylate, 
and it was observed repeatedly that the oxygen uptake 
at all plasma salicylate concentrations was linear 
over a period of 2—3 hours, indicating that therapeut 
salicylate/
42 .
/salicylate had reached its site of action inside 
the cells.
leucocytes from Patients on Salicylate Therapy
(Sodium salicylate concentration of 
100 ml.) plasma 40 mg. per
Time in 
mins. A t. Flask 1. AHeading. Flask 2. A Heading.
Zero - 150.0 - - 150 —
10 10 144*0 6.0 145.0 5.0
32 10 138*5 5*5 140.0 5.0
3° 10 132.0 6.5 134.5 5.5
40 10 126.0 6.0 1 3 1 .0 4.5
50 10 120.5 5*5 125.0 5.0
60 10 114.0 6.5 120.0 5.0
90 30 96.5 17*5 104.0 16.0
120 30 78.0 18.5 89.0 15.0
150 30 60.5 17.5 64.5 15.5
180 30 42.0 18.5 - 50.5 14.5
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If the salicylate were exerting its effect at the 
surface of the cell, it would he expected that, as 
the cell was hathed in a salicylate-free buffer 
medium, any sai-icylate molecules would he washed 
off the membrane and the oxygen consumption of 
the system would steadily decrease*
Results of these two experiments are shown in 
Figure lf p. 44.
The oxygen consumption of the leucocytes does 
not begin to increase until the concentration of 
salicylate in the patient's plasma has exceeded 
20 mg. per 100 ml. This agrees with the finding 
of Alexander and Johnston (1958) that the metabolic 
rate did not begin to increase significantly on 
salicylate administration until the plasma salicylate 
concentration reached 20 mg. per 100 ml* Lester,
Lolli and Greenberg (1946) studied the ability of 
human plasma to bind salicylate in vivo and in vitro.
They found that the proportion of bound salicylate 
in plasma decreases with increasing concentrations 
of total salicylate. At a level of 4 mg. per 100 
ml., SOfo was bound; at 16 mg. per 100 ml., IQfo was 
bound; at 70 mg. per 100 ml., 54$.
When the plasma salicylate concentration lies 
in the range 20-60 mg. per 100 ml., the increase in 
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/concentration of 60 mg. per 100 ml. is exceeded, 
symptoms of salicylism (dizziness, tinnitus, nausea, 
etc.) develop rapidly.
It is also interesting to note that the minimal 
therapeutic plasma concentration of salicylate is 
generally taken to he about 20 mg. per 100 ml., and 
relief of rheumatic symptoms does not occur, or is 
not maintained, unless the plasma concentration is 
above this level.
Effect of Salicylate in vitro.
The effect of salicylate on the respiration of 
leucocytes was further studied by determining the 
oxygen consumption of leucocytes from normal blood 
after they had been re-suspended in buffer containing 
various concentrations of sodium salicylate. Blood 
was obtained from eight healthy subjects (medical 
students) whose total and differential leucocyte 
count was within normal limits (see Table VII).
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TABLE VII. Total and Differential Leucocyte Counts?
_of the Normal Subjects whose Leucocytes
were used for In vitro Studies with Salicylate.
(Cf. Table VIII and Figure 2).
Total leucocyte count in cells per cu. mm. blood.
Poly. Lymph. Mono. Eosin. Basoph.
gect.
Total.
W.B.C. f * fo f... f
1. 6,940 72 22 5 1 0
2. 7,200 71* 23* •D X JS 0
3* 5,250 50 41 7 1* 12
4. 5,420 62* 33* 2* 1* 0
5. 5,020 48 41 6* 4* 0
6. 5,920 64 31* 3* 1 0
T. 6, 260 66 28* 4 1* 0
Si- 4,360 56 36 6 2 0
Means 61 32 5 2 0
In each experiment, Warburg flasks were set up 
containing zero, 10, 20, 40, 60, 80, and 160mg. sodium 
salicylate per 100 ml. of buffer medium, and to each 
flask was added an equal number of leucocytes. The 
rate of oxygen consumption was then determined in the 
usual way. Results are shown in Table VIII, and the 
combined/
/combined result of all eight experiments is shown 
graphically in Figure 2.
TABLE VIII. The in vitro Effect of Sodium Salicylate 
on the Oxygen Consumption of Normal 
Human Leucocytes.
Results expressed in p. moles O2 per hour per 10? 
leucocytes.
Salicylate concentration in mg. per 100 ml.
Subject. Zero 10. 20. 40. 1°̂ lo * 80. 160.
1. 0.137 0.146 0.156 0.196 0.100 0.069 0.050
2. 0.097 0.104 0.149 0.168 0.115 — 0.044
3» 0.086 0.089 0.128 0.106 0.097 0.076 0.050
4. 0.125 0.148 — 0.240 0 .144 0.113 0.085
5. 0.107 - 0.165 0.196 0.150 0.104 0.074
6. 0.110 0.140 0.158 0.197 - 0.113 0.085
7* 0.106 - 0.132 0.164 0 .114 O.O84 0.046
8. 0.109 0.150 0.199 0.230 0.152 0.098 —
Figure 2 shows the changes in the rate of oxygen 
consumption, compared with zero time, at the 
corresponding salicylate concentrations. Each point 
on the graph represents the mean change in oxygen 
consumption corresponding to the salicylate concentration 
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The oxygen consumption increased up to a 
maximum corresponding to a salicylate concentration 
of 40 mg. per 100 ml. medium, and thereafter, 
progressively decreased. Concentrations of 
salicylate greater than 70 mg. per 100 ml. medium 
depressed the normal rate of oxygen consumption.
The importance of maintaining a constant pH in 
the Warburg flasks has "been referred to ahove (p. 28). 
Sodium salicylate is slightly acid in aqueous 
solution (pH = 5-6). The buffer solution used is 
sufficiently powerful to maintain the pH constant 
to within +0.02 unit when the sodium salicylate 
concentration is increased up to the maximum value 
used - 160 mg. per 100 ml. The changes shown in 
Figure 2 are not, therefore, due to alteration of the 
pH.
The only previously recorded work on the in vitro 
effect of salicylate on O2 uptake of cells, is the 
dose-response curve using mouse liver slices, 
reported by Sproull (1954)# Sproull's curve is 
very similar to that shown in Figure 2. The oxygen 
consumption of the mouse liver slices increased with 
increasing salicylate concentration, reaching a 
maximum between 32-48 mg. salicylate per 100 ml. 
Thereafter, as the salicylate concentration was 
further increased, the oxygen consumption decreased, 
and/
50.
/and at concentrations greater than 80 mg. salicylate 
per 100 ml., the rate of oxygen consumption was less 
than normal.
With mouse liver slices, Sproull found that the 
maximum stimulation hy salicylate resulted in an 
increased rate of oxygen consumption of +22$. Using 
leucocytes, maximum stimulation at the salicylate 
concentration of 40 mg. per 100 ml., was +72$ 
which is more in keeping with the increase in the 
total oxygen consumption of the subject during 
salicylate administration (Alexander and Johnston, 
1958) which may increase the metabolic rate by as 
much as +45$. There are several possible reasons 
for this: (a) the method of preparation of the
suspension of leucocytes results in little damage 
to the cells, (b) each leucocyte is independently 
bathed by the medium so that there is no danger of 
anoxia, and this is demonstrated by the fact that 
leucocytes respire at a constant rate for at least 
three hours under the conditions of these experiments.
When salicylate is administered to the subject, 
the rate of oxygen consumption of the leucocytes 
increases over the range 20-60 mg. salicylate per 
100 ml. plasma (Figure 1, p. 44); when salicylate 
is added to the system in vitro, the rate of oxygen 
consumption of the leucocytes increases over the range 
0/
51.
/0-40 mg, salicylate per 100 ml. medium (Figure 2, p. 48). 
In the former case, there is evidence that the circulating 
salicylate is partly hound to the plasma protein, and 
therefore not available to the cells (Lester, lolli 
and G-reenberg, 1946) whereas in the latter case, the 
method of preparation of the leucocyte suspension 
involves removal of almost all the plasma protein 
(see p. 24 ) and the cells are then suspended in what 
is virtually a protein-free salt solution.
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RELATIONSHIP BETWEEN THE OXYGEN UPTAKE OF LEUCOCYTES 
AND THE BASAL METABOLIC RATE.
It has been shown (Figure 1, p. 44) that there 
is a direct relationship between the oxygen uptake 
of leucocytes and the concentration of salicylate 
in the plasma; it has also been shown by Alexander 
and Johnston (1958) that there is a direct relationship 
between the concentration of salicylate in the plasma 
and the metabolic rate of the subject. The next 
development is the investigation of the direct 
relationship between oxygen uptake of the leucocytes 
and the metabolic rate. For this purpose, a series 
of hyperthyroid and myxoedematous patients, and a 
series of euthyroid control subjects, have been 
investigated. In each case, the patients and control 
subjects were studied under basal conditions. The 
basal metabolic rate was first determined by the 
Benedict-Roth method. Immediately afterwards, blood 
was taken for determination of the oxygen consumption 
of the leucocytes.
The patients were classified by the usual clinical 
methods supported by laboratory examinations, including 
the estimation of the basal metabolic rate. Results 
are set out in the Tables immediately following*
TABLE IX. Rate of Oxygen Consumption of Leucocytes
and Basal Metabolic Rate.
Hyperthyroid Cases.
Oxygen Consumption is expressed in p. moles O2 per hour 
per 107 leucocytes.
Basal Metabolic Rate is expressed in Cals. per m^ per hour.
Oxygen uptake
Subject. Sex. Age. Basal Metabolic Rate. of Leucocytes.
A. E. 41. 58 0.240
B-l. E. 44. 49 0 .181
B-2. E. 49. 51 O .238
C. E. 52. 48 0.192
E. E. 23. 70 0.119
/ L. E. 34. 53 0.150
M. E. 46. 50 0.198
P. E. 57. 45 0.144
q . E. 37. 51 0.182
S-l. E. 55. 47 0.134
S-2. E. 49. 56. 0.194
T. E. 24. 47 0.183
W. E. 71. 54 0 .210
S. E. 36. 51 0.230
Means of 14 cases 53 0.185
Standard deviations 6 0.037
TABLE X . Rate of Oxygen Consumption of Leucocytes
and Basal Metabolic Rate,
Myxoedematous Cases.
Oxygen Consumption is expressed in jx moles O2 per hour 
per 10*7 leucocytes.
Basal Metabolic Rate is expressed in Cals. per m2 per hour.
Oxygen Uptake
Subject. Sex. Age. Basal Metabolic Rate. of Leucocytes.
B. P. 48. 27 0.063
p. P. 64* 30 0.097
MeC. P. 59. 26 0.094
McP-1. P. 38. 26 0.084
McP-2. P. 3 8. 30 0.077
Mel. P. 59. 24 0.077
McK. P. 64* 23 0.095
McL. P. 54. 26 0.-074
P. P. 66. 24 0.118
R. M. 35. 19 0.050
Means of 10 cases 26 O.O83
Standard deviations 2 0.016
Total and differential white cell counts were
carried out on eight cases of hyperthyroidism (Table IX) 
and on eight cases of myxoedema (Table X). All values 
were found to be within the normally accepted limits.
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TABLE XI. Rate of Oxygen Consumption of Leucocytes
and Basal Metabolic Rate.
Euthyroid (control) Subjects. (Cp. Tahle III, p. 3 4).
Oxygen Consumption is expressed in moles O2 per hour 
per 10*7 leucocytes.
Basal Metabolic Rate is expressed in Cals, per m? per hour.
Oxygen Uptake
Subject. Sex. Age. Basal Metabolic Rate, of Leucocytes.
A. M. 29. 36 0.086
E. M. 20. 52 0.138
F* F. 17. 46 0.123
Gr. M. 28. 31 0.112
MeD. M. 3°. 29 0.155
M . M. 25. 42 0.091
P-l. F. 32 0.145
P-2. F* 66. 30 0.123
R-l. M. 26. 36 0.096
R-2. M. 35 v 29 0.118
S. F* 60. 35 0.113
W. F. 68. 45 0.125
Means of 12 subjects 37 0.119
Standard deviations 8 0.021
Hote: Subject R-2 in the above table is the same asCase R in Table X. The values given above were 






















Correlation of leucocyte oxygen uptake and B.M.R. 
in Hypothyroid, Euthyroid and Hyperthyroid cases.
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X = 182x + 15-23 
r = 8-77 err = 0.74 
95?̂  confidence limits + 17-8
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The data in Tables IX, X, and XI, are shown 
graphically and compared in Figure 3. The correlation 
between basal metabolic rate and the oxygen consumption 
of the leucocytes is very satisfactory with one single 
exception.
Having determined this relationship, the point 
was further examined by following the changes in 
basal metabolic rate and in leucocyte oxygen consumption 
in myxoedematous and hyperthyroid patients before and 
after appropriate treatment. Three cases of myxoedema 
were selected at random and treated in the usual way 
with 1-thyroxine until the basal metabolic rate of 
each had reached the normal range. Similarly, three 
cases of hyperthyroidism were treated with radioactive 
iodine. The changes in basal metabolic rate and in 
leucocyte oxygen consumption resulting from therapy 
are shown graphically in Figure 4. The actual 
protocols of Figure 4 are given in Table XII (p. 59).
In all six cases, the basal metabolic rate and the 
leucocyte oxygen consumption change in the same 
direction under treatment. The thyroxine is converted 
to "thyroid hormone" which increases both quantities; 
the radioactive iodine suppresses production of "thyroid 
hormone" in the thyroid gland and thereby leads to a 
decrease in both quantities. The matter will be more 






















Effect of treatment on oxygen uptake of leucocytes 
from hyperthyroid and myxoedematous patients.
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TABLE XII. The Effect of Treatment on the Basal Metabolic 
Rate and on Leucocyte Oxygen Consumption in 
Cases of Myxoedema and Hyperthyroidism.
(Cp. Figure 4, p. 58).
Oxygen Consumption is expressed in /u moles O2 per hour 
per 10? leucocytes.
Basal Metabolic Rate is expressed in Cals. per m2 per hour. 
Hyperthyroid Cases: Treated with I3ll.
Patient: Anderson. Quinn. Waterhouse.
B.M.R. before therapy. 57.9 51.4 54.0
Leucocyte oxygen uptake 
before therapy. 0.240 0.182 0.210
Dose o f ^ I . 13 me, 12 me . 10 me
B.M.R. after therapy. 40.5 35.9 36.2
Leucocyte oxygen uptake 
after therapy. 0.196 0.106 0.135
Myxoedema Cases: Treated with 1-Thyroxine •
Patient: Brogan,, McIntyre. Roy.
B.M.R. before therapy. 27.0 24.0 19.0
Leucocyte oxygen uptake 
before therapy. 0.063 0.077 0.050






B.M.R. after therapy. 31.5 47.0 45.0
Leucocyte oxygen uptake 
after therapy. 0.163 0.187 0.190
bO.
The Effect of Triiodothyroacetic Acid on the Oxygen 
Uptake of the Leucocytes of Myxoedematous Patients.
It has been demonstrated (l) that the leucocyte 
oxygen uptake is directly proportional to the 
metabolic rate of the patient being high in 
hyperthyroidism and low in myxoedema (p. 56), and 
(2) that leucocyte oxygen consumption varies with 
the thyroid activity of the patient, being increased 
in cases of myxoedema treated with 1-thyroxine, and 
decreased in cases of hyperthyroidism treated with
x31l (p. 5 8 ).
The acetic acid analogues of 1-thyroxine and 
triiodothyronine (namely, tetraiodothyroacetic acid 
and triiodothyroacetic acid respectively) have been 
found to raise the metabolic rate of thyroidectomised 
and hypophysectomised rats without delay (Thibault and 
Pitt-Rivers (1955); Thibault (1955); and Danhoffer 
(1956)).
In hypophysectomised rats, intravenous injection 
of a few micrograms of TRIAC is invariably followed 
by a marked rise in total body oxygen consumption 
and in body temperature, while only about half of the 
thyroidectomised, and none of the intact rats showed 
a similar response (Varnai (1957)).
The/
bl •
/The next experiment in this series was designed to 
observe the effect of TRIAC on the oxygen consumption 
of the leucocytes in cases of myxoedema* It is not 
an easy matter to obtain suitable patients for such 
experiments* Cardiac lesions are not ■uncommon in 
myxoedema and an injection of TRIAC exerts a 
considerable strain on the patient's heart muscle 
and may produce a severe fibrillation* Consequently, 
such experiments are confined to relatively young 
subjects in whom no secondary cardiac lesion is 
demonstrable. Most hospital cases of myxoedema are 
elderly and not uncommonly have cardiac lesions 
demonstrable by electrocardiography, and in such cases, 
intravenous injection of TRIAC is not without danger.
The first case was a young woman aged 30* Tke 
patient had fasted and rested for 12 hours, then the 
basal metabolic rate was determined, and immediately 
afterwards, blood was withdrawn to determine the 
basal rate of oxygen consumption of the leucocytes.
5*0 mg. of triiodothyroacetic acid (in the form of the 
ethanolamine salt) in saline solution was injected 
intravenously. The basal metabolic rate was determined 
60, 120 and 390 minutes after injection, and blood was 
taken for determination of the leucocyte oxygen uptake 
30, 60, 120 and 180 minutes after injection. Results 
are shown in Table XIII.
TABLE XIII* Effect of Injection of TRIAC in a Case of
Myxoedema*
Case 1. (see also Figure 5> p. 63).
Oxygen uptake is expressed in p moles O2 per hour per 
107 leucocytes.
Metabolic Rate is expressed in Cals. per m2 per hour.
Time relative to Oxygen uptake Metabolic
the injection. of leucocytes. Rate.
- 30 minutes. O.I38 37.9
+ 30 minutes. 0.165 -
+ 60 minutes. 0 .2 3 0 . 4 0 .1
+ 120 minutes. 0.285 43*0
+ 180 minutes. 0 *3 0 0 -































Effect of injection of TRIAC on the oxygen uptake 
of leucocytes and B.M.R. of a myxoedematous patient.
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The second case was a young woman aged 20. The 
experiment was repeated as above, the only difference 
being the timing of the observations. The basal 
metabolic rate was determined 60, 120, 180 and 240 
minutes after injection of TRIAC, and blood was taken 
for leucocyte oxygen uptake 60, 120 and 180 minutes 
after injection. Results are shown in Table XIV.
TABLE XIV. Effect of Injection of TRIAC in a Case of 
Myxoedema,
Case 2, (see also Figure 6, p. 65).
Oxygen uptake is expressed in p moles O2 per hour per 
10? leucocytes.
Metabolic Rate is expressed in Cals. per m2 per hour.
Time relative to Oxygen uptake Metabolic
the injection. of leucocytes. Rate.
- 30 minutes. 0.059 -
Zero. 0.054 24.0
+ 60 minutes. 0.056 24*0
+ 120 minutes. 0.059 26.7
+ 180 minutes. 0.081 26.7
+ 240 minutes. - 29*1
65.
Figure 6.
Effect of an injection of TRIAC on the oxygen 
uptake of leucocytes and B.M.R. of a myxoedematous 
patient.
0 200
~ o. 150 -
0 -1 0 0 -
=  0  050  -





— 30 Zero ■+ 60 +  240+ 120 + 180 +  300
Time — minutes
6b
The limiting factor in this section of the work 
was the availability of suitable patients, and few 
conclusions can be drawn from only two experiments.
The oxygen uptake of the leucocytes corresponds with 
the basal metabolic rate in each patient, and the 
different resjjonse of the two patients is far beyond 
the limits of experimental error of both determinations. 
Consequently, one. is forced to conclude that the two 
patients have responded quite differently to the 
injection of TRIAC. This may possibly correspond 
with the variations in response found by Varnai (1957)> 
described above.
In the second patient, the response to TRIAC is 
only small (but significant at 180 minutes) and is 
considerably delayed. This may be associated with 
the fact that the second patient was much more 
hypothyroid than the first, and might have required 
a larger dose of TRIAC to produce the increases 
obtained with the first patient. But at the time 
of injection, it was felt that 5*0 mg. TRIAC was the 
maximal dose that could be given with safety.
These matters require further experimentation, 
and this in turn, depends on the available number of 
suitable patients.
THE EFFECT OF TRIIODOTHYROACETIC ACID ON THE OXYGEN
UPTAKE OF NORMAL HUMAN LEUCOCYTES.
Thibault and Pitt-Rivers (1955) obtained an 
immediate stimulation of oxygen consumption of 
kidney slices from thyroidectomised rats by addition 
to the system of the compound 3:5:3'-triiodothyroacetic 
acid (TRIAC). Donhoffer, Varnai and Szeibert-Horvath 
(1958) recorded an immediate increase in metabolic 
rate and in body temperature by injecting TRIAC into 
hypophysectomised rats. Having already studied the 
metabolic stimulation of the oxygen consumption of 
normal leucocytes in vitro with sodium salicylate 
(above, p. 48), it was of interest to determine 
whether TRIAC would also act as a metabolic stimulant 
of the oxygen consumption of normal leucocytes in vitro.
The procedure was similar to that carried out using 
sodium salicylate as stimulant. Normal leucocytes 
were isolated by the method previously described 
from the blood of 8 normal healthy subjects. These 
leucocytes were then suspended in the modified Krebs'
No. 2 buffer. Warburg flasks were set up containing 
zero, 10, 15, 20, 25, 35 and 50 micrograms TRIAC per 
100 ml. medium. The cell suspensions were added to 
these flasks and the rate of oxygen consumption was 
determined. The results obtained are shown in
Table XV f and Figure 7, p. 67a.
Figure 7»
The effect of TRIAC on the oxygen uptake of normal 
human leucocytes in vitro.
in
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TABLE XV. The in vitro Effect of Triiodothyroacetic 
Acid on the Oxygen Consumption of Normal 
Human Leucocytes.
(Cp. Table VIII, p. 47).
Results expressed in p. moles O2 per hour per 10^ leucocytes.
TRIAC cone. in micrograms per 100 ml. medium.
Subject. Zero. 10. ±1- 20. 25. 35. 50.
1. 0.073 0.077 0.072 0.071 0.076 - 0.072
2. 0.122 0.102 0.106 0.116 0.112 0.104 0.116
3. 0.190 0.174 0.200 0.170 0.180 0.184 0.186
4* 0.115 0.116 0.111 — 0.104 0.109 0.106
5* 0.110 0.114 0.112 0.116 0 .1 3 0 0.114 0.126
6. 0.095 0.099 0.108 - 0.107 0.105 0.108
7. 0.072 0.076 0.069 0.081 0.078 0.076 0.078
8. 0.123 0.134 0.140 0.126 0.120 0.134 0.134
It is clear from these results that TRIAC does not 
cause any stimulation of normal leucocyte respiration 
in, vitro, thereby differing completely from sodium 
salicylate.
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THE OXYGEN CONSUMPTION OF LEUCOCYTES IN GASES
OF LEUKAEMIA.
Leukaemia is a morbid condition of unknown 
aetiology and fatal termination which is characterised 
by widespread proliferation of leucocytes and their 
precursors in the tissues of the body. In particular, 
it is associated with both qualitative and quantitative 
changes in the circulating white cells of the blood.
It is probable that the disorder is fundamentally one 
of growth control, but it is also likely that 
abnormalities occur in the metabolism of the leukaemic 
cell itself and a study of these metabolic abnormalities 
may yield further knowledge of the elementary difference 
between normal and leukaemic leucocytes.
Since the effects of two metabolic stimulants, 
sodium salicylate and triiodothyroacetic acid, on the 
oxygen uptake of normal human leucocytes had been 
studied, the effects of these two stimulants on 
leukaemic leucocytes were then investigated.
Two groups were studied - chronic myeloid leukaemia 
and chronic lymphatic leukaemia. Eight patients from 
each group were available. Because of the high whife 
cell counts, only 2 0 -3 0 elL. of blood were required from 
each case, a considerable technical advantage. Since 
two experiments were carried out on each patient, two 
control/
70.
/control values for the oxygen uptake of the leucocytes 
were obtained on each subject. The patients came up 
to hospital as out-patients and were not always in a 
completely basal state before blood was withdrawn.
All the control values have been collected together 
and are shown in Table XVI.
TABLE XVI. The Oxygen Consumption of Leukaemic Leucocytes. 
All results are given in ji moles O2 per hour per 107 cells.
Chronic myeloid leukaemia. Chronic lymphatic leukaemia.
Case. Oxygen uptake. Case. Oxygen uptake.
1 a. 0.182 1 a. 0.176
b. 0.145 b. 0.169
2 a. 0.097 2 a. 0.182
b. 0.221 b. 0.125
3 a. 0.102 3 a. 0.164
b. 0.112 b. 0.100
4 a. 0.104 4 a. 0.194
b. 0.096 b. . 0.147
5 a. 0 .1 3 0 5 a. 0.145
b. 0.116 b. 0.248
6 a. 0.101 6 a. 0.148
b. 0.127 b. 0.149
7 a. 0.152 7 a. 0.126
b. 0.116 b. 0.195
8 a. 0.136 8 a. 0.142




It is not considered that these values are 
significantly different either from each other or 
from the values obtained for normal human leucocytes 
(Table III, p. 34). This is in accordance with the 
findings of Beck and Valentine (1953) and Bird,
Clements and Becker (1951).
The leucocyte counts were as follows 
Chronic myeloid leukaemia:
W.B.C. 80,000 to 720,000 per mm3. (average = 210,000) 
Myeloid cells. 96$ of the total.
Chronic lymphatic leukaemia:
W.B.C. 79,000 to 282,000 per mm3. (average = 160,000)
Lymphocytes. 92 - 97$ of the total. (average = 94$) 
Lymphoblasts. 1 - 4$ of the total. (average = 2j$).
METABOLIC STIMULATION BY SALICYLATE. LEUKAEMIC CELLS.
It will be recalled that with normal human 
leucocytes, addition of salicylate in vitro first 
stimulates and then depresses the oxygen consumption 
(Table VIII, p. 47, and Figure 2, p. 4 8 ). The 
technique was exactly the same as that used in the 
study of normal leucocytes (see p. 46). The only 
minor difference was that these leukaemic patients 
were not strictly basal when the blood was withdrawn, 
but since the values obtained were referred to the 
control for each subject, it is not considered that 
this difference had any significant bearing on the 
conclusions reached. In this connection, it has 
long been known that the basal metabolic rate is 
increased in both chronic myeloid and in chronic 
lymphatic leukaemias (Biddle and Sturgis, 1927,
Krantz and Riddle, 1928, and many others).
Results with cases of chronic myeloid leukaemia 
are shown in Table XVII and in Figure 8; with cases 
of chronic lymphatic leukaemia in Table XVIII and in 
Figure 9.
TABLE XVII. The in vitro Effect of Sodium Salicylate on
the Oxygen Consumption of Human Leucocytes 
from cases of Chronic Myeloid Leukaemia*
Results are expressed in ji moles O2 per hour per 107 cells*
Salicylate concentration in mg. per 100 ml.
Subject. Zero. 10. 20. IS • 60. I00 |o • 160.
Gilmour. 0.176 0.210 0.263 ir\OJ.O 0.230 0.224 -
Murray• 0.182 0.172 0.182 0 .2 1 3 0.222 0.215 0.200
Gobi). 0.164 0.176 0.190 — 0.200 0.235 -
Rafferty. 0.194 0.200 0.215 0.225 0.247 0.268 0 .2 3 0
Cattanach. 0.145 0.161 0.170 0.175 0.190 - 0.177
Wood. 0.149 0.162 0.168 0.178 0.192 0.175 0.160
Lamberton. 0.195 0.205 0.220 0.240 0.188 0.152 —
Smith. 0.142 0.205 0.188 0.156 0.149 — 0.140
Eigure 8 shows the changes in the rate of oxygen 
consumption, compared with zero time, at the corresponding 
salicylate concentrations* Each point on the graph 
represents the mean change in oxygen consumption 
corresponding to the salicylate concentration; the 
feet represent the standard errors of each mean.
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Figure 8*
The effect in vitro of sodium salicylate on the 
oxygen consumption of human leucocytes from cases 
of Chronic Myeloid leukaemia*
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TABLE XVIII. The in vitro Effect of Sodium Salicylate on 
the Oxygen Consumption of Human Leucocytes 
from cases of Chronic Lymphatic Leukaemia. 
Results are expressed in |i moles 02 per hour per 107 cells.
Salicylate concentration in mg. per 100 ml.
Subject. Zero. o|HI 20. 40. o|^1 80. 160.
McLaughlin. 0.182 0.192 0.204 0.220 0.215 0.192 0.145
McMillan* 0.102 0.112 0.120 0.120 0.102 0.093 0.069
Walker• 0.104 0 .1 3 0 0.136 0.123 0.111 0.086 0.081
McCluskey. 0.094 0.116 0.120 0.124 0 .1 3 1 0.134 0.143
Smith. 0 .1 3 0 0.147 0.161 0.117 0.102 0.102 0.071
Darner. 0.101 0.136 0.112 0.108 — 0.099 0.076
McCutcheon. 0.152 0.186 0.203 0.175 0.145 0.117 0.104
Stewart. 0.136 0.155 0.157 0.168 0.156 — 0.144
Eigure 9 shows the changes in the rate of oxygen
consumption, compared with zero time, at the corresponding 
salicylate concentrations. Each point on the graph 
represents the mean change in oxygen consumption 
corresponding to the salicylate concentration; the 



















The effect in vitro of sodium salicylate on the oxygen
uptake of human leucocytes from cases of Chronic
lymphatic leukaemia.
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The behaviour, under these conditions, of the 
leucocytes from myeloid leukaemic blood is quite 
different from normal human blood (Cp. Figures 8 and 
2, p. 74 and p. 48). Salicylate stimulates myeloid 
cells to a much smaller extent than normal cells, 
but whereas the maximal stimulation with normal cells 
is reached at a concentration of 40 mg. salicylate 
per 100 ml., it is not reached with myeloid cells 
until a concentration of 80 mg. per 100 ml. by which 
level of concentration respiration is depressed whoa 
normal cells are used. Furthermore, even at a 
concentration of 160 mg. salicylate per 100 ml., 
the myeloid cells are still respiring at a rate which 
is greater than normal - a concentration which severely 
inhibits the oxygen consumption of normal leucocytes.
Lymphatic leukaemic leucocytes under these 
conditions, are also different from normal leucocytes 
(Cp. Figures 9 and 2, p. 76 and p. 4 8 ) but resemble; 
their behaviour more closely than do myeloid leucocytes. 
Comments on these differences will be found in the 
Discussion.
7b.
METABOLIC STIMULATION BY TRIIODOTHYROACETIC ACID.
LEUKAEMIC CELLS.
It has already heen shown that triiodothyroacetic 
acid (TRIAC) in vitro does not stimulate the oxygen 
consumption of normal human leucocytes (p.67a) and 
Table XV, p. 68). The experiments with normal 
cells leading to that conclusion have been repeated 
using leucocytes from cases of chronic myeloid and 
chronic lymphatic leukaemia.
Results with cases of chronic myeloid leukaemia 
are shown in Table XIX and in figure 10; with cases 
of chronic lymphatic leukaemia in Table XX and in 
figure 11*
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TABLE XIX, The in vitro Effect of Triiodothyroacetic
Acid on the Oxygen Consumption of Leucocytes 
from Cases of Chronic Myeloid Leukaemia. 
Results are expressed in jti moles O2 per hour per 107 cells.
TRIAC concentration in micrograms per 100 ml*
Subject. Zero. 10. !§.• 20. SI- 35. lo •
Gilmour. 0.169 0.183 0.188 0.195 0.207 0.205 0 .2 0 5
Murray, 0.125 0 .1 3 1 0.149 0.139 0.132 0.128 0.117
Gibb. 0.100 0.100 0.105 0.108 - 0.114 0.126
Rafferty. 0.149 0.155 — 0.170 — 0.168 0.160
Cattenach. 0.248 0.264 0.278 0.288 0.275 - 0.240
Wood. 0.148 0.151 0.160 0.159 0.168 0.150 0.150
lamberton. 0.126 0.130 0.134 0.144 0.156 - '• 0.146
Smith. 0.143 0.152 0.156 0.160 0.162 0.167 0.143
Figure 10 shows the changes in the rate of oxygen 
consumption, compared with zero time, at the corresponding 
TRIAC concentration. Each point on the graph represents 
the mean change in oxygen consumption at that concentration; 
the feet represent the standard error of each mean.
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Figure 10.
The effect in vitro of TRIAC on the oxygen uptake
of leucocytes from cases of Chronic Myeloid
Leukaemia*
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TABLE XX. The in vitro Effect of Triiodothyroacetic Acid
on the Oxygen Consumption of Leucocytes from 
Cases of Chronic Lymphatic Leukaemia.
Results are expressed in )u. moles O2 per hour per 10? cells.
TRIAC concentration in micrograms per 100 ml.
Subject. Zero. 10. il- 20. 25. 35. §£•
McLaughlin. 0.145 - 0.149 0.153 0.156 0.153 0 .1 4 2
McMillan• 0.112 0.115 0.110 0.114 0.116 0.105 -
Walker. 0.096 0.102 0.104 0.102 0.099 0.102 0 .1 0 2
McCluskey. 0.221 0.225 0.213 0.216 0.204 0.201 0 .1 9 0
Smith. 0.116 0.118 0.119 0.115 0.115 - 0.118
Darner. 0.127 0.123 0.136 0.126 0.131 O.lgl 0.128
Me Cute he on. 0.116 0.122 0.123 0.128 0.128 0.127 0.124
Stewart. 0.126 0 .1 2 8 0.123 0.124 0.126 0.132 0.110
Figure 11 shows the changes in the rate of oxygen 
consumption, compared with zero time, at each TRIAC 
concentration. Each point on the graph represents 
the mean change in oxygen uptake at that concentration; 
the feet represent the standard error of each mean.
Figure 11.
The effect in vitro of TRIAC on the oxygen uptake
of leucocytes from cases of Chronic Lymphatic
Leukaemia.
m
g +  0  0 4
&








SO4 0lO 3 020O
T r ia c  C o n c e n tra t io n  _ p g / I O O  mI medium
When TRIAC .was added to chronic myeloid leukaemic 
leucocytes, a positive response was obtained. The 
myeloid cells showed a significant increase in oxygen 
consumption at all concentrations from 10 - 35 
micrograms TRIAC per 100 ml. of medium, maximum 
stimulation occurring at a concentration of 25 
micrograms per 100 ml. At this point, the oxygen 
consumption was 15$ above the control value. Furthermore, 
with myeloid cells, stimulation of oxygen consumption 
occurred at all concentrations of TRIAC which were 
studied.
Over the same range of TRIAC concentrations, chronic 
lymphjatic leukaemic leucocytes showed no significant 
response. At 4 of the 6 concentrations of TRIAC, 
oxygen uptake was slightly, but not significantly, 
above the control value; in the other 2 concentrations, 
it was slightly, but again not significantly, below the 
control value. It is most likely that these results 
are simply variations about a mean.
Thibault and Pitt-Rivers (1955) obtained an 
immediate effect with TRIAC in vitro using kidney 
slices taken from thyroidectomised rats. Donhoffer, 
Varnai and Szeibert-Horvath (1958) also obtained an 
immediate effect with TRIAC in vivo using thyroidectomised 
and adrenalectomised rats. Heimberg, Park, Isaacs and 
Pitt-Rivers (1955) also obtained an immediate response 
to TRIAC in vitro using mouse ascites tumour cells.
DISCUSSION.
This work was approached with two main objects 
in view. One was an attempt to evolve some method 
of estimating total body metabolism, and the other, 
to examine respiration at cell level and to observe 
the effects of metabolic stimulants on this respiration.
Total body metabolism is measured by determining 
the basal metabolic rate, or the metabolic rate, and 
this determination is notoriously liable to be 
affected by numerous intrinsic and extrinsic factors, 
of which we need only mention age, sex, diet, 
excitability (in the normal individual), metabolic 
disease, respiratory difficulties in the common 
Benedict-Roth method of estimating the basal metabolic 
rate, and so on. It is generally recognised that the
first two or three estimations of a patient’s basal 
metabolic rate are worthless, and that it is not 
until the fourth or fifth attempt, that reliable 
results can be obtained. All clinical biochemists 
are aware of the impossibility of attempting a 
differential diagnosis between hysteria and a mild 
or moderate hyperthyroidism in a young female, by 
means of the Benedict-Roth apparatus. The problem 
then arose, whether or not one could obtain living 
cells from the human body, whose respiration 
was/
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/was representative of the respiration of the body 
as a whole.
The only cells which are readily available for 
this purpose are those circulating in the blood.
The erythrocytes are of no use since, apart from 
the question of whether they are “living” or not, 
their respiration rate is so small that there is 
some doubt if they respire at all. Furthermore, 
they are not to be regarded as typical body cells 
since the mature erythrocyte is the only cell in the 
body which is non-nucleated. One must therefore 
fall back on the leucocytes. These cells are free- 
floating, can be easily counted in any system, have a 
high rate of respiration, and a priori, are in some 
form of chemical equilibrium with all the tissues of 
the body. On the other hand, leucocytes are easily 
damaged by laboratory manipulation and are difficult 
to separate undamaged from erythrocytes. There are 
also several different cell types which, although 
relatively constant in health and in many diseases, 
may be drastically altered in other diseases, e.g. 
the leukaemias.
It is not the object of this work to provide an 
alternative to routine hospital determinations of the 
basal metabolic rate. In spite of the disadvantages 
of the basal metabolic rate as a method of investigation, 
it/
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/it is unlikely that the Benedict-Roth apparatus will 
ever he replaced routinely by the Warburg apparatus, 
whatever the advantages of the latter. In all 
probability the Warburg apparatus will always remain 
a research tool, and it was with this in mind that 
the work presented here was attempted. Its outstanding 
advantage as a method of investigations is that its 
use eliminates subjective variations in the determination 
of the rate of metabolism.
Respiration at cell level can be followed only in 
an apparatus such as the Warburg apparatus which is 
eminently suitable for the present purposes - namely 
the effect of added metabolic stimulants, whether 
added in vivo or in vitro. This apparatus also makes 
easy the study of day-to-day variations, especially 
of patients undergoing treatment.
Little need be said here about the actual technique 
of using the Warburg apparatus, or its standardisation. 
The most important practical point with the system 
employed was the adequate control of the pH. The 
only tehcnical difficulty encountered was traced to 
the use of a basic medium, the pH of which was too 
low, and this was counteracted by the addition of 
disodium hydrogen phosphate to a final pH of 7.40 +
0.05. Preliminary experiments showed that the oxygen 
consumption per hour per 10? leucocytes did not depend 
on/
/on the total number of cells present in the flask 
(Table I, p. 30); replicate estimations gave very 
good agreement in the great majority of cases (Table II, 
p. 31); and in a series of 16 normal subjects, the 
average oxygen consumption of the leucocytes was found 
to be 0.111 p moles of oxygen per hour per 10? cells, 
with a standard deviation of 0 .0 2 3.
Perhaps the greatest single difficulty in 
determining the basal metabolic rate is the problem 
of getting the patient in a truly "basal” condition.
The use of an isolated cell system will certainly 
eliminate many variables, but such a system may 
still be affected by hormonal stimulantspoured out 
into the blood in response to environmental changes.
The total white cell count, but not the differential 
white cell count, varies with exercise. Typical 
changes are shown in Table IY (p. 37). The changes 
are irregular, and are largely eliminated by expressing 
results in values per 10? cells, since changes in the 
differential white cell count are insignificant.
The effect of exercise on the oxygen uptake of 
leucocytes is shown in Table Y (a) (p. 3 8 ) and is 
compared with the corresponding effect of exercise 
on the subject's metabolic rate (Table Y (b), p. 39). 
Both are increased - the former much more than the 
latter. This is to be expected since the leucocytes 
are one of the first types of cell to be exposed to 
any/
bo*
/any changes in the hody chemistry. Since exercise 
increases the oxygen consumption of isolated leucocytes, 
it is still necessary to obtain standards for reference 
while the subject is in the basal state, but this is 
comparatively easy when nothing more than venepuncture 
is the only manipulation involved. There is no 
evidence that venepuncture causes any significant 
change in the leucocyte oxygen uptake (see p. 40).
The data in Table V (a) and (b) show that the 
increase in leucocyte oxygen consumption is almost 
twice the increase in body oxygen consumption after 
exercise. Presumably this leucocyte stimulation 
is due to the secretion of adrenaline or some compound 
of similar biological activity. In a paper on the 
metabolism of leucocytes by Beck and Valentine (1953) 
the rate of oxygen consumption by leucocytes has been 
reviewed in detail, but no mention is made of blood 
specimens having been collected from subjects while 
they were in the ‘'basal” state, and the wide 
divergence of results recorded by various authors 
clearly points to this omission as one of the main 
causes of the variation of the reported normal values.
Experiments with Salicylate.
In order to he useful to the "body, and not be 
directly lost as heat, oxidative energy is employed 
to esterify inorganic phosphate into high-energy 
phosphate bonds during the process of electron transfer 
to oxygen. The efficiency of oxidation is often 
expressed as the MP:0 ratio”, i.e., the number of 
moles of phosphorus esterified divided by the number 
of moles of oxygen utilised. The level of high-energy 
phosphate present, the amount being utilised and hence 
the availability of some acceptor for such energy 
(e.g. glucose-hexokinase) is believed to control the 
rate cf tissue oxidation. In other words, the race of 
most tissue oxidations is normally dependent upon, or 
coupled to, the formation of energy-rich phosphate bonds.
The in vitro action of salicylate is qualitatively 
similar to that of 2:4-dinitrophenol. Both are 
believed to uncouple oxidative phosphorylation, to 
stimulate the respiration of an acceptor-deficient 
system, to inhibit fatty acid oxidation, and to 
stimulate the hydrolysis of adenosine triphosphate. 
(Meade, 1954; Smith and Jeffrey, 1956; Brody, 1956; 
Pennial, 1956). In particular, Brody (1956) showed 
that at high concentration of sodium salicylate, the 
P:0 ratio was reduced almost to zero, i.e., at high 
salicylate/
90.
/salicylate concentrations, the production of energy-rich 
phosphate bonds was greatly reduced and the cell (in this 
case, kidney mitochondria) no longer produced the energy 
necessary for survival.
The drug-response curve obtained with human 
leucocytes over the range 0 - 160 mg. sodium salicylate 
per 100 ml. medium is similar in shape to that obtained 
with mouse liver slices by Sproull (1954). Figure 2 
(p. 48) shows that the oxygen uptake of leucocytes 
increases in direct proportion to the salicylate 
concentration up to 40 mg. per 100 ml. medium, and 
thereafter, the respiration rate decreases. Sproull 
found maximal stimulation at a concentration of 32-48 
mg. salicylate per 100 ml., and further increase in 
salicylate concentration resulted in a decrease of 
oxygen uptake.
The considerable similarity between the responses 
of two entirely different cell systems is sufficiently 
encouraging to suggest that the action of sodium 
salicylate on different cells has a common basis.
Since salicylate stimulates leucocyte respiration 
both in vivo (see Figure 1, p. 44) and when added 
in vitro (see Figure 2, p. 48) the question arose as 
to whether this response was the result of sodium 
salicylate having an action on the cell surface or if 
the salicylate was acting on the respiratory enzymes 
within/
91.
/within the cell, having first penetrated the membrane*
The oxygen consumption of leucocytes from the blood 
of two patients on salicylate therapy was studied, and 
the results (see Figure 1, p* 44) show that, with 
increasing concentration of salicylate, the oxygen 
uptake of the leucocytes increased* Prior to the 
determination of the oxygen consumption, almost the 
whole of the plasma (containing the administered 
salicylate) had been removed and the leucocytes were 
then suspended in a salicylate-free medium, and it was 
repeatedly observed that the oxygen uptake at all the 
(original) plasma salicylate concentrations was linear 
over a period of 2-3 hours, indicating that the 
salicylate administered therapeutically had reached 
its site of action. If the salicylate were exerting 
its effect at the surface of the cell, it would be 
ejected that, as the cell was bathed in a salicylate- 
free medium, any salicylate would be washed off the 
surface of the membrane and the oxygen consumption of 
the cell system would steadily decrease. It is 
highly unlikely that the salicylate exerts any action 
on cell respiration if it is simply adsorbed on the 
outer surface of the cell, and hence the conclusion 
is that the active salicylate has penetrated the cell 
membrane and is exerting its effect on the respiratory 
enzymes within the cell protoplasm.
Each/
92.
/Each cell requires a fixed amount of energy for its 
ordinary metabolic processes. Part of this energy 
is derived from glycolysis, of the rest of the 
necessary energy, the bulk comes from oxidative 
phosphorylation. Salicylate, like 2:4-dinitrophenol, 
is known to uncouple oxidative phosphorylation, i.e., 
for a fixed amount of energy, the cell requires more 
oxygen for oxidation within the tricarboxylic acid 
cycle - hence the increase in oxygen uptake on addition 
of limited amounts of salicylate to the system. The 
decrease in oxygen uptake when the salicylate concentration 
is increased beyond 40 mg. per 100 ml., and the later 
depression of oxygen consumption when the salicylate 
concentration is increased beyond about 70 mg. per 100 
ml. (see Figure 2, p. 48) are presumable nothing more 
than toxic effects which might be brought about by any 
chemical agent.
The response of leucocytes from cases of chronic 
myeloid leukaemia (see Figure 8, p. 74) is quite different 
from that of normal leucocytes. There are several 
possible explanations of this difference. The cell 
membrane may be less permeable to salicylate ions; 
the metabolic processes of the myeloid cell may be less 
dependent on oxidative phosphorylation than the normal; 
or the metabolic processes of the myeloid cell may be 
less sensitive to the toxic action of high concentrations 
of/
93.
/ofsalicylate. Of these possibilities, the first 
would seem to he the most prohahle since, at an 
external concentration of 160 mg. salicylate per 
100 ml. of medium, the myeloid cell is still 
respiring at a greater rate than the control 
value, while with normal or lymphatic leukaemic 
cells, this concentration of salicylate causes a 
marked dpression of oxygen consumption.
Thyroid Stimulation of Oxygen Consumption.
It has heen shown ahove (1) that exercise 
increases the oxygen consumption of leucocytes hy 
more than 50$ under the conditions selected, and 
that this increase is almost twice as great as the 
increase in metabolic rate of the subject under the 
same conditions, and (2) that addition to a leucocyte 
suspension of a metabolic stimulant such as sodium 
salicylate can increase the oxygen consumption of the 
leucocytes by more than 70$, while administration of 
salicylate in the normal therapeutic dose does not 
increase the metabolic rate of the patient by more 
than approximately 45$ (Alexander and Johnson, 1958).
As further evidence of the correlation between 
leucocyte oxygen consumption and total body metabolism, 
we might collect together the data given in the text 
for/
94.
/for the leucocyte oxygen consumption in hyperthyroid, 
euthyroid, and hypothyroid subjects.
Number Oxygen consumption.

















The rate of oxygen consumption agrees with the 
clinical state of the patient, and the individual 
variation is greatest in.the hyperthyroid group, 
as would be expected, and least in the myxoedema 
group, as would also be expected. These figures 
also show that thyroid hormon has a direct effect 
on the oxygen consumption of circulating leucocytes.
This correlation is again shown by the effect 
of treatment on the oxygen consumption of leucocytes 
in cases of hyperthyroidism and of myxoedema (see 
Figure 4> p. 58, and Table XII, p. 59). Since the 
hyperthyroid cases were treated withal I, and the 
myxoedema cases were treated with 1-thyroxine, the 
changes in the oxygen consumptions of the leucocytes 
must/
95.
/must have been due to the changes in the concentration 
of the circulating hormone in the patients' blood.
There is much evidence that an intact cell structure 
is an essential preliminary to the study of hormone 
action. The effect of TRIAC has been examined both 
in the intact human subject, and simultaneously, on 
the isolated leucocytes of the same subject in cases 
of myxoedema. The considerable difficulties in 
obtaining suitable subjects have already been 
mentioned (see p. 61). Only two patients have been 
obtained so far on whom this experiment could be 
safely performed, and the response of these two 
patients was quite different (see figures 5 and 6, 
pp. 63 and 65). The first showed an immediate 
response to TRIAC by an increase in both the leucocyte 
respiration rate and the total body metabolic rate.
The second showed a delayed increase in leucocyte 
respiration and an irregular increase the total 
body metabolic rate. This difference cannot be 
resolved without a further supply of suitable 
patients. The discrepancy is not necessarily due 
to experimental error, for similar irregularities 
have been described in animal work.
Yarnai (1957) studied the effect of TRIAC 
injection in rats. Using hypophysectomised animals, 
intravenous injection of a few microgram was invariably 
followed/
96.
/followed "by a marked rise in oxygen consumption and 
in "body temperature; using a normal intact animal, 
such changes were never observed; with thyroidectomised 
rats approximately half responded by a marked increase 
in oxygen consumption and in body temperature, the 
others did not. Donhoffer, Varnai and Szeibert-Horvath 
(1958) confirmed these results obtained with hypo- 
physectomised rats and showed that both effects were 
completely abolished by the prior administration of 
1 mg. of cortisone. They concluded that depressed 
adrenal cortical function was a necessary factor in 
the production of an increase in oxygen consumption 
and in body temperature following injection of TRIAC.
In this work, they also observed that (1) no immediate 
response (in terms of increased oxygen consumption 
and of increased body temperature) could be obtained 
in hypophysectomised rats adequately treated with 
ACTH; (2) this immediate response to TRIAC injection 
could be elicited within 16 hours of removal of the 
pituitary gland; and (3) the immediate response in 
the hypophysectomised rat is not abolished by 
elevating the reduced metabolic rate to normal or 
supra-normal levels by prior administration of 1-thyroxine.
The different responses in the two patients studied 
in this work, may possibly be related to adrenal function 
although there was no clinical evidence of cortical 
adrenal/
9
/adrenal hypofunction in the case of the patient who 
responded to TRIAC injection. It is not suggested 
that the discrepancy can he explained in terms of 
results obtained by experiments on animals.
It is known that about 60°/<> of cases of primary 
myxoedema are extinct Hashimoto's disease. In 
Hashimoto's disease, the lymphocytes produce an 
antibody to the thyroid hormone. Perhaps the 
leucocytes from such a patient react differently 
from leucocytes from a true primary myxoedema to 
TRIAC circulating in the blood stream. Further 
cases, suitable for investigation, are required 
before any conclusion can be drawn.
The Effects of Triiodothyroacetic acid (TRIAC).
Since the thyroid hormones and salicylate are 
both metabolically active substituted phenols,
Du Toit (1952) suggested that both might act by 
uncoupling oxidative phosphorylation in the same 
way as do certain other substituted phenols such 
as 2:4-dinitrophenol and various halogenated 
phenols. In the previous year, Martins and Hess
(1 9 5 1) had shown that when 1-thyroxine was auued 
in vitro to normal mitochondrial preparations, the 
esterification of AMP and ADP to ATP was reduced; 
and/
9b.
/and Maley and landy (1953) and Hoch and lipmann (1954) 
both showed that thyroxine and triiodothyronine depressed 
the P:0 ratio in normal respiring mitochondrial 
preparations. In such systems, landy and Maley (1954) 
provided evidence that one of the actions of 2:4- 
dinitrophenol was to increase the activity of ATP-ase, 
and that thyroxine and triiodothyronine had similar 
effects. However, the uncoupling of oxidative 
phosphorylation cannot be accounted for solely in 
terms of ATP-ase activation, and attempts to identify 
the specific locus at which the thyroid hormone 
uncouples oxidative phosphorylation have not yet 
been successful*
In this work, triiodothyroacetic acid in vitro 
was found to have no significant effect on the rate of 
oxygen uptake of normal leucocytes (Table XV , p. 68) 
or of leucocytes isolated from cases of chronic 
lymphatic leukaemia (Table XX, p. 81). On the other 
hand, addition of triiodothyroacetic acid in vitro 
causes a significant increase in the rate of oxygen 
consumption of leucocytes isolated from cases of 
chronic myeloid leukaemia (TableXEX, p. 79)* In all 
three cases, the results are clear-cut and there are 
sufficient data to justify this conclusion*
Although the experiment has been attempted on 
several occasions recorded in the literature, no one 
has/
99.
/has ever “been able to demonstrate an in vitro effect 
on theoxygen consumption of normal cells or tissues 
by addition of thyroxine, triiodothyronine or 
triiodothyroacetic acid to the system (Klemperer (1955) 
and several others). This work adds the normal 
leucocyte to the other types of cells which have been 
studied* Either the cells of normal tissues are 
"saturated" with thyroid hormone, or, in isolated 
systems, the cell membranes are impermeable to the 
various thyroid hormones which have been tried out.
lymphocytes isolated from cases of chronic 
lymphatic leukaemia do not respond in vitro to the 
addition of TRIAC. This is in keeping with the 
findings of Barker (1955) who examined the effect 
of thyroid hormone in vitro on various tissues 
isolated from thyroidectomised rats. He found that 
lymph nodes were among the tissues which did not 
respond to TRIAC (see p. 23)* Since these thyroid 
hormones are thought to be carboxylic acids, Barker 
suggested that the explanation was to be found in 
the fact that lymph nodes, and lymphocytes as well, 
are very rich in decarboxylase and that the thyroid 
hormones were inactivated by this enzyme.
Cells of the myeloid series isolated from cases 
of chronic myeloid leukaemia do respond in vitro to 
the addition of TRIAC. Now, normal polymorphonuclear 
leucocytes/
1 0 0 .
/leucocytes are also formed in bone marrow and are 
of the same series as the myeloid cells, hence the 
in vitro response of myeloid cells to TRIAC represents 
a metabolic abnormality. It may be recalled at this 
point that Heimberg et al (1955) showed that ascites 
tumour cells also responded in vitro to the addition 
of TRIAC by increased oxygen consumption rate and an 
increased rate of glycolysis (see p. 22).
The f ailure of the lymphocytic leukaemic cell to 
respond to the addition of TRIAC in vitro is of no 
immediate practical importance since, apart from the 
negative response, it belongs to a different series 
of leucocyte from the normal polymorph and the myeloid 
leukaemic cell. The response of the myeloid leukaemic 
cell to TRIAC in vitro is slight, but significant, and 
since the normal leucocyte population does not respond 
under these circumstances, one must conclude that the 
metabolism of the myeloid leukaemic cell has become 
deranged, and there is a certain amount of evidence 
that this metabolic derangement may be due to a slight 
hormonal imbalance.
Certain differences between the normal leucocyte 
population (which belongs mainly to the granulocytic 
series) of the blood, and leucocytes from cases of 
chronic myeloid leukaemia have already been recorded 
in the literature. Valentine, Eollette and Lawrence 
(1953)/
1 0 1 .
/(1953) found that the normal granulocyte has almost 
twice as much glycogen per cell as the chronic myeloid 
leukaemic cell, and if the former is regarded as normal, 
the latter must have an abnormally low glycogen content.
It is a known fact that in cortisone deficiency, e.g., 
in Addison's disease, the cell glycogen content is 
also abnormally low. It is therefore possible that 
the chronic myeloid leukaemic cell is deficient in 
cortisone or some closely related glucocorticoid 
hormone•
Valentine and Beck (1951) have shown that the 
normal granulocytic leucocyte has five times as much 
alkaline phosphatase activity as the chronic myeloid 
leukaemic cell, and it has been shown that the 
administration in vivo of A.C.T.H., cortisone, or 
hydrocortisone can induce a 3- or 4-fold increase in 
the alkaline phosphatase activity of the normal 
granulocytic leucocyte. This would also indicate 
that the chronic myeloid leukaemic cell is deficient 
in one or more of the steroid adrenal hormones. There 
is no record in the literature of the effect of A.C.T.H., 
or any of the adrenal cortical hormones on the alkaline 
phosphatase activity of the leucocytes from the blood 
of patients with chronic myeloid leukaemia.
A third difference is the one recorded here, namely, 
that the leucocytes from cases of chronic myeloid leukaemia 
show/
1 0 2 .
/show a significant response to the addition of TRIAC 
in vitro whereas the normal leucocyte does not.
The work by Varnai and his co-workers referred to 
above (p. 96) has shown that the TRIAC effect in 
hypophysectomised rats could be completely abolished 
by prior administration of cortisone.
All of these results lead to the conclusion 
that the leucocytes in cases of chronic myeloid 
leukaemia may be deficient in a specific corticoid 
hormone. The precise nature of this chemical is 
not known, but presumably it is a glucocorticoid with 
=0 at Oil, and it is hoped to pursue this research along 
these lines*
Ecclesiastes, Chap. 1, v. 18*
103.
S U M M .
1. Normal human leucocytes, taken from patients 
under basal conditions respire at a rate of 
0.111 + 0.023 V1 aioles per hour per 10? cells.
2. Moderate exercise by the blood donor, prior to 
venepuncture results in an average increase in 
oxygen consumption of the leucocytes of 54$ 
over the control level.
3. The oxygen consumption of leucocytes taken 
from patients on salicylate therapy, increases 
with increasing salicylate concentration between 
20-60 mg. per 100 ml. plasma. Between 0-20 mg. 
salicylate per 100 ml. plasma, there is no increase 
in oxygen consumption.
4. In vitro, normal human leucocytes show a response 
to sodium salicylate. Between 0-40 mg. sodium 
salicylate per 100 ml. medium, the oxygen 
consumption increases with increasing salicylate 
concentration, reaching a maximum at 40 mg. per 
100 ml. Between 40-70 mg. per 100 ml. medium, 
the respiration decreases and from 70-160 mg. per 
100 ml. medium, the oxygen consumption is depressed 
to values lower than normal.
5./
1 0 4 .
/5* There is a direct relationship between the 
oxygen uptake of leucocytes and B.M.R. of 
the patient. Thirty-six patients with 
different degrees of thyroid activity were 
studied. The leucocytes from hyperthyroid 
patients had an oxygen uptake of 0.185 + 0 .0 3 7  
p moles per hour per 10^ cells. leucocytes 
from euthyroids had an oxygen uptake of 0.119
+ 0.021 ji moles per hour per 10? cells.
The leucocytes from myxoedematous patients 
had an oxygen uptake of O.O83 + 0.016 jut moles 
per hour per 107 cells.
6. The oxygen consumption of leucocytes from three 
cases of myxoedema and three cases of hyper­
thyroidism was studied before and after therapy.
In the three cases of myxoedema, the oxygen 
consumption of the leucocytes increased.with 
thyroxine therapy. In the three cases of 
hyperthyroidism the oxygen consumption of the 
leucocytes decreased with ^3li therapy.
7. An injection of 5 mg. TRIAC was given to two 
myxoedematous patients and the oxygen uptake 
of the patients1 leucocytes was determined at 
fixed intervals after injection. The leucocytes 
from the first patient gave a significant increase 
in/
105.
/in oxygen consumption at 30 minutes. At 2 
hours the oxygen consumption had increased 
by more than 100$. The second patient gave 
no significant increase in oxygen consumption 
until 3 hours after injection. At that time, 
there was an increase in oxygen uptake of the 
leucocytes of 50$.
8. There was no increase in oxygen uptake of 
leucocytes from normal patients with TRIAC 
in the range 0 -5 0 ug. per 100 ml. medium.
9. Leucocytes from eight cases of Chronic lyeloid 
Leukaemia (Myeloid cells 96$ of the total) 
had an oxygen uptake of 0.126 + 0 .0 3 9 p moles 
per hour per 10? cells. Leucocytes from 
eight cases of Chronic Lymphatic Leukaemia 
(lymphocytes:- 94$) had an oxygen uptake of 
0.160 + 0.032 p moles per hour per 10^ cells.
It is not considered that these values are 
significantly different either from each other, 
or from the values obtained for normal human 
leucocytes.
10. Salicylate was added in vitro to leucocytes 
from eight cases of Chronic Myeloid Leukaemia 
and eight cases of Chronic Lymphatic Leukaemia.
The response of the two types of leukaemic 
leucocytes to salicylate was different.
Salicylate/
106.
/Salicylate stimulates myeloid cells to a 
much smaller extent than normal cells, maximum 
stimulation is not reached until a concentration 
of 80 mg. sodium salicylate per 100 ml. medium. 
At a concentration of 160 mg. salicylate per 
100 ml., the myeloid cells are still respiring 
at a rate which is greater than normal. The 
stimulation of oxygen uptake with lymphatic 
leukaemia leucocytes is small but definite, 
reaching a maximum at 20 mg. per 100 ml. medium. 
Between 20-70 mg. per 100 ml. medium, the 
oxygen uptake is depressed. Between 70-160 mg. 
the oxygen uptake is less than the control. 
Inhibition of oxygen uptake with lymphatic 
leukaemic leucocytes is much less than with 
normal leucocytes.
11. The in vitro effect of TRIAC (0-50 pg. per 100 
ml. medium) was studied with leucocytes from 
eight cases of Chronic Myeloid Leukaemia and 
eight cases of Chronic Lymphatic Leukaemia. 
Myeloid leukaemic leucocytes responded to 
TRIAC by increase in oxygen consumption. 
Lymphatic leukaemic leucocytes gave no response.
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